
### [MONDO:0020045](http://purl.obolibrary.org/obo/MONDO_0020045)
**Label:** autosomal recessive cerebellar ataxia due to a DNA repair defect

**Subclasses:** [MONDO:0011457](http://purl.obolibrary.org/obo/MONDO_0011457) (ataxia-telangiectasia-like disorder), [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), [MONDO:0018996](http://purl.obolibrary.org/obo/MONDO_0018996) (spinocerebellar ataxia with axonal neuropathy type 2), [MONDO:0019600](http://purl.obolibrary.org/obo/MONDO_0019600) (xeroderma pigmentosum), [MONDO:0016354](http://purl.obolibrary.org/obo/MONDO_0016354) (xeroderma pigmentosum-Cockayne syndrome complex), 

**Corr. equiv. classes:** [Orphanet:100](http://www.orpha.net/ORDO/Orphanet_100), [OMIM:194400](http://purl.obolibrary.org/obo/OMIM_194400), [OMIM:278780](http://purl.obolibrary.org/obo/OMIM_278780), [OMIM:278760](http://purl.obolibrary.org/obo/OMIM_278760), [Orphanet:251347](http://www.orpha.net/ORDO/Orphanet_251347), [Orphanet:64753](http://www.orpha.net/ORDO/Orphanet_64753), [OMIM:208910](http://purl.obolibrary.org/obo/OMIM_208910), [OMIM:615217](http://purl.obolibrary.org/obo/OMIM_615217), [OMIM:610651](http://purl.obolibrary.org/obo/OMIM_610651), [OMIM:208900](http://purl.obolibrary.org/obo/OMIM_208900), [Orphanet:220295](http://www.orpha.net/ORDO/Orphanet_220295), [OMIM:278700](http://purl.obolibrary.org/obo/OMIM_278700), [Orphanet:910](http://www.orpha.net/ORDO/Orphanet_910), [OMIM:606002](http://purl.obolibrary.org/obo/OMIM_606002), [OMIM:278730](http://purl.obolibrary.org/obo/OMIM_278730), [OMIM:278740](http://purl.obolibrary.org/obo/OMIM_278740), [OMIM:604391](http://purl.obolibrary.org/obo/OMIM_604391), [OMIM:278720](http://purl.obolibrary.org/obo/OMIM_278720), 

**Class expressions from DL-Learner:**

- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) 63.89%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0004334](http://purl.obolibrary.org/obo/HP_0004334) (Dermal atrophy) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 63.89%
- [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0004334](http://purl.obolibrary.org/obo/HP_0004334) (Dermal atrophy) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 63.89%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 63.89%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 63.89%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 63.89%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 63.89%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 63.89%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 63.89%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 63.89%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 63.89%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 63.89%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0008065](http://purl.obolibrary.org/obo/HP_0008065) (Aplasia/Hypoplasia of the skin) 63.89%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0004334](http://purl.obolibrary.org/obo/HP_0004334) (Dermal atrophy) 63.89%
- [HP:0000504](http://purl.obolibrary.org/obo/HP_0000504) (Abnormality of vision) and [HP:0001029](http://purl.obolibrary.org/obo/HP_0001029) (Poikiloderma) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 63.89%


